ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Ripasudil, a Rho kinase inhibitor, attenuates testosterone-induced benign prostatic hyperplasia in rats: targeting inflammation, oxidative stress, and Rho kinase pathways.

Randa Hisham Aljorani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.